Les précédentes recommandations de 2014 ont été actualisées par un groupe de travail
constitué de 12 experts rhumatologues, deux représentants des associations de patients et un …

Cet article présente les recommandations de la Société française de rhumatologie pour la
prise en charge de la polyarthrite rhumatoïde (PR). Ces recommandations ont été élaborées …

Background: Prevalence estimates of rheumatoid arthritis (RA) vary across Europe. Recent
estimates in southern European countries showed a lower prevalence than in northern …

Objective: To assess the tolerance and efficacy of rituximab in patients with various
autoimmune diseases seen in daily rheumatological practice. Methods: 866 rheumatology and …

Objective: To estimate the prevalence of spondyloarthropathies (SpAs) in France in a
multiregional representative sample in the year 2001. Methods: A two stage random sample was …

Objective A number of open‐label studies have suggested the potential benefit of rituximab (RTX)
in systemic lupus erythematosus (SLE). However, in 2 recent randomized controlled …

Background Patients who have had inadequate response to tumour necrosis factor inhibitors
have fewer treatment options and are generally more treatment refractory to subsequent …

OBJECTIVE: Rheumatoid arthritis is associated with increased cardiovascular morbidity and
mortality. We performed a systematic review of the literature and a meta-analysis to look for …

Objective To test if interleukin‐1β (IL‐1β), IL‐1 receptor antagonist (IL‐1Ra), IL‐4, or IL‐10
gene polymorphisms could be used as markers of susceptibility or severity in rheumatoid …

Background Skin psoriasis precedes the onset of psoriatic arthritis (PsA) in 84% of patients
with psoriasis. Dermatologists have an important role to screen psoriasis patients for PsA. …